Literature DB >> 26536192

Survival After Sublobar Resection Versus Lobectomy for Clinical Stage IA Lung Cancer: Analysis From the National Cancer Database.

Jessica S Donington1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26536192     DOI: 10.1097/JTO.0000000000000674

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  6 in total

1.  Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.

Authors:  Raymond U Osarogiagbon; Meredith A Ray; Nicholas R Faris; Matthew P Smeltzer; Carrie Fehnel; Cheryl Houston-Harris; Raymond S Signore; Laura M McHugh; Paul Levy; Lynn Wiggins; Vishal Sachdev; Edward T Robbins
Journal:  Ann Thorac Surg       Date:  2017-03-31       Impact factor: 4.330

Review 2.  [Progress of Lung Margin During Sublobar Resection for Early-staged Non-small Cell Lung Cancer].

Authors:  Zongkai Wang; Mingjian Ge
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-06-20

3.  Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.

Authors:  Sushant Kumar Das; Ke-Wei Fang; Long Xu; Bing Li; Xin Zhang; Han-Feng Yang
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

4.  Imbalanced Data Correction Based PET/CT Radiomics Model for Predicting Lymph Node Metastasis in Clinical Stage T1 Lung Adenocarcinoma.

Authors:  Jieqin Lv; Xiaohui Chen; Xinran Liu; Dongyang Du; Wenbing Lv; Lijun Lu; Hubing Wu
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

5.  [Chinese Experts Consensus on Artificial Intelligence Assisted Management for 
Pulmonary Nodule (2022 Version)].

Authors: 
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-03-28

6.  Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States.

Authors:  Raymond U Osarogiagbon; Helmneh M Sineshaw; Chun Chieh Lin; Ahmedin Jemal
Journal:  Chest       Date:  2020-11-14       Impact factor: 9.410

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.